drugset / Trial / NCT07734311

A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

NCT07734311 ↗

Phase 3 Recruiting 360 enrolled Hangzhou Sciwind Biosciences Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of the study is to evaluate the efficacy and safety of ecnoglutide injections versus placebo in obese participants with KOA.

Timeline

Start
2026-08-03
Primary completion
2028-05-31
Completion
2028-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecnoglutide Protein / enzyme biologic — Subcutaneous